Roche (RHHBY) presented at ASPORS meeting primary results of the Phase 3 SatraGO-1 and SatraGO-2 trials — Efficacy and Safety of Satralizumab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback